Cargando…
Follow-up Care for Patients Receiving Immune Checkpoint Inhibitors
The rapid advances in cancer immunotherapy using immune checkpoint inhibitors (ICIs) have led to significantly improved survival of patients. But at the same time, it also associates with multiple immune-related adverse events (irAEs). The irAEs can affect a wide range of organs, and induce nonspeci...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522586/ https://www.ncbi.nlm.nih.gov/pubmed/34790843 http://dx.doi.org/10.4103/apjon.apjon-2129 |